Astria Therapeutics Inc
(ATXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 14,668 | 30,474 | N/A | N/A |
| TOTAL | $15,022 | $30,581 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 288 | 308 | N/A | N/A |
| Other Non-Current Assets | 654 | 113 | 0 | 0 |
| TOTAL | $942 | $421 | $N/A | $N/A |
| Total Assets | $15,964 | $31,002 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,132 | 651 | 0 | 0 |
| Accrued Expenses | 2,793 | 2,279 | N/A | N/A |
| TOTAL | $4,234 | $2,930 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 4,439 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 198 | 110 | 0 | 0 |
| TOTAL | $4,637 | $110 | $N/A | $N/A |
| Total Liabilities | $8,871 | $3,040 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 1 | N/A | N/A | N/A |
| Retained earnings | -75,380 | -53,496 | N/A | N/A |
| Other shareholders' equity | 80,146 | 80,146 | 0 | 0 |
| TOTAL | $7,093 | $27,962 | $N/A | $N/A |
| Total Liabilities And Equity | $15,964 | $31,002 | $0 | $0 |